Cefiderocol Activity Improves in Physiologic Media, Synergizes With LL-37
Cefiderocol MICs fell against Pseudomonas aeruginosa and Klebsiella pneumoniae, and the drug showed marked synergy with LL-37 against resistant Acinetobacter baumannii. Jacinda…
PR
By Priya Raman · Science Reporter
Nov 2 08:24 ETSource: Contagion Live
From the source
Read at contagionlive.comCefiderocol Activity Improves in Physiologic Media, Synergizes With LL-37
Cefiderocol MICs fell against Pseudomonas aeruginosa and Klebsiella pneumoniae, and the drug showed marked synergy with LL-37 against resistant Acinetobacter baumannii. Jacinda Abdul-Mutakabbir, PharmD, MPH, AAHIVP, discusses her team's findings around this therapy and these pathogens.
